Research use only — not for human or veterinary consumption.  ·  Read the policy

ARA-290

Erythropoietin-Derived Peptide

≥ 99% HPLCWhite lyophilised powder

1 vial size, from 130.50 AUD. Verify the batch on your vial in the COA library.

ARA-290 research peptide vial, Erythropoietin-Derived Peptide
$130.50
In stock
Vial size · 10 mg
Research use only. Not for human or veterinary consumption. The controlling document is the batch-specific certificate of analysis published for your vial's lot.

Overview

An 11-residue peptide derived from the erythropoietin helix B sequence, supplied as a lyophilised powder for in-vitro research. Released against a batch-matched third-party certificate of analysis.

repairerythropoietin-derived

Specification

CompoundARA-290
FormWhite lyophilised powder
Purity≥ 99% (HPLC)
TestingThird-party HPLC, batch-matched COA
ReconstitutionBacteriostatic water
StorageStore sealed and dry at 2–8 °C. Protect from light.
Intended useIn-vitro laboratory research only